Home›Companies›Biotech & Pharma›TAVRA Biosciences

Tavra Biosciences LLC

Supplies bone marrow-derived stem cell products to licensed physicians.

Updated Nov 10, 2026·Latest SEC filing Apr 15, 2026·Suggest an edit

About TAVRA Biosciences

TAVRA Biosciences is a private company based in Plano, Texas, incorporated in 2026 in Texas. It has reported $300,000 raised in one offering on Form D since April 2026. Its chief executive is Priya Chordia.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Mar 31, 2026Apr 15, 2026$300,000of $2.0M target2$150KEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on TAVRA Biosciences's Form D filed Apr 15, 2026.

Sources

  1. SECTAVRA BIOSCIENCES LLC filing history
  2. CompanyTerms of Use
  3. CompanyTAVRA Biosciences News and Media